AI for Pre-Symptomatic Schizophrenia: Redefining Early Mental Health Diagnostics

Schizophrenia spectrum disorders (SSD) progress through distinct phases, with early detection in pre-acute stages (pre-morbid and prodromal) being critical for timely intervention and improved clinical outcomes. Traditional diagnostic approaches, such as the Structured Interview for Prodromal Syndromes (SIPS) and the Scale of Prodromal Symptoms (SOPS), often struggle with subjectivity, scalability, and the subtle nature of early symptoms, leading to significant diagnostic delays. To address these limitations, this study proposes an AI-driven framework that leverages multimodal data, including behavioral observations, structured clinical interviews, psychometric scales, and neurophysiological markers (e.g., EEG). Our approach integrates these diverse data sources using machine learning models to identify complex cognitive, emotional, and social deviations characteristic of SSD's pre-acute phases. We validate our framework using a synthetic dataset simulating early-stage symptoms, demonstrating superior sensitivity and specificity compared to traditional methods. The system also supports longitudinal tracking, enabling continuous risk assessment and early intervention. Our findings underscore the potential of AI to transform early SSD detection, reducing diagnostic latency and improving patient outcomes.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-09-30
DOI
https://doi.org/10.5281/zenodo.17236314
Primary Topic
Biological and pharmacological studies of plants
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

AI for Pre-Symptomatic Schizophrenia: Redefining Early Mental Health Diagnostics

Zenodo (CERN European Organization for Nuclear Research)
Biological and pharmacological studies of plants
article

AI for Pre-Symptomatic Schizophrenia: Redefining Early Mental Health Diagnostics

article en

Abstract

Schizophrenia spectrum disorders (SSD) progress through distinct phases, with early detection in pre-acute stages (pre-morbid and prodromal) being critical for timely intervention and improved clinical outcomes. Traditional diagnostic approaches, such as the Structured Interview for Prodromal Syndromes (SIPS) and the Scale of Prodromal Symptoms (SOPS), often struggle with subjectivity, scalability, and the subtle nature of early symptoms, leading to significant diagnostic delays. To address these limitations, this study proposes an AI-driven framework that leverages multimodal data, including behavioral observations, structured clinical interviews, psychometric scales, and neurophysiological markers (e.g., EEG). Our approach integrates these diverse data sources using machine learning models to identify complex cognitive, emotional, and social deviations characteristic of SSD's pre-acute phases. We validate our framework using a synthetic dataset simulating early-stage symptoms, demonstrating superior sensitivity and specificity compared to traditional methods. The system also supports longitudinal tracking, enabling continuous risk assessment and early intervention. Our findings underscore the potential of AI to transform early SSD detection, reducing diagnostic latency and improving patient outcomes.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 41%
Biological and pharmacological studies of plants
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.